Literature DB >> 32133160

Switching off DNA repair-how colorectal cancer evades targeted therapies through adaptive mutability.

Jörg Fahrer1.   

Abstract

Keywords:  Cancer genetics; Gastrointestinal cancer; Preclinical research

Year:  2020        PMID： 32133160      PMCID： PMC7035417          DOI： 10.1038/s41392-020-0120-3

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN： 2059-3635


× No keyword cloud information.
  10 in total

Review 1.  Immunotherapy in colorectal cancer: rationale, challenges and potential.

Authors:  Karuna Ganesh; Zsofia K Stadler; Andrea Cercek; Robin B Mendelsohn; Jinru Shia; Neil H Segal; Luis A Diaz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-06       Impact factor: 46.802

2.  Adaptive mutability of colorectal cancers in response to targeted therapies.

Authors:  Mariangela Russo; Giovanni Crisafulli; Alberto Sogari; Nicole M Reilly; Sabrina Arena; Simona Lamba; Alice Bartolini; Vito Amodio; Alessandro Magrì; Luca Novara; Ivana Sarotto; Zachary D Nagel; Cortt G Piett; Alessio Amatu; Andrea Sartore-Bianchi; Salvatore Siena; Andrea Bertotti; Livio Trusolino; Mattia Corigliano; Marco Gherardi; Marco Cosentino Lagomarsino; Federica Di Nicolantonio; Alberto Bardelli
Journal:  Science       Date:  2019-11-07       Impact factor: 47.728

Review 3.  Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies.

Authors:  NaNa Keum; Edward Giovannucci
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08-27       Impact factor: 46.802

Review 4.  Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies.

Authors:  Christine M Parseghian; Stefania Napolitano; Jonathan M Loree; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2019-07-01       Impact factor: 12.531

Review 5.  Colorectal cancer.

Authors:  Ernst J Kuipers; William M Grady; David Lieberman; Thomas Seufferlein; Joseph J Sung; Petra G Boelens; Cornelis J H van de Velde; Toshiaki Watanabe
Journal:  Nat Rev Dis Primers       Date:  2015-11-05       Impact factor: 52.329

Review 6.  Mutation as a stress response and the regulation of evolvability.

Authors:  Rodrigo S Galhardo; P J Hastings; Susan M Rosenberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2007 Sep-Oct       Impact factor: 8.250

Review 7.  Mechanism of colorectal carcinogenesis triggered by heme iron from red meat.

Authors:  Nina Seiwert; Daniel Heylmann; Solveig Hasselwander; Jörg Fahrer
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-11-26       Impact factor: 10.680

8.  A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.

Authors:  Sabrina Arena; Giorgio Corti; Erika Durinikova; Monica Montone; Nicole M Reilly; Mariangela Russo; Annalisa Lorenzato; Pamela Arcella; Luca Lazzari; Giuseppe Rospo; Massimiliano Pagani; Carlotta Cancelliere; Carola Negrino; Claudio Isella; Alice Bartolini; Andrea Cassingena; Alessio Amatu; Gianluca Mauri; Andrea Sartore-Bianchi; Gloria Mittica; Enzo Medico; Silvia Marsoni; Michael Linnebacher; Sergio Abrignani; Salvatore Siena; Federica Di Nicolantonio; Alberto Bardelli
Journal:  Clin Cancer Res       Date:  2019-12-12       Impact factor: 12.531

9.  PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression.

Authors:  Bastian Dörsam; Nina Seiwert; Sebastian Foersch; Svenja Stroh; Georg Nagel; Diana Begaliew; Erika Diehl; Alexander Kraus; Maureen McKeague; Vera Minneker; Vassilis Roukos; Sonja Reißig; Ari Waisman; Markus Moehler; Anna Stier; Aswin Mangerich; Françoise Dantzer; Bernd Kaina; Jörg Fahrer
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-09       Impact factor: 11.205

10.  β-Lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity.

Authors:  A Gutierrez; L Laureti; S Crussard; H Abida; A Rodríguez-Rojas; J Blázquez; Z Baharoglu; D Mazel; F Darfeuille; J Vogel; I Matic
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.